Stratasys TrueDent Becomes the First High-esthetic, Monolithic 3D-printed Denture Solution to Achieve Certification in Europe, a $2 Billion+ Market

Key Terms

ce marking regulatory

CE marking is a symbol placed on certain products showing they meet European Union safety, health and environmental rules required to sell them in the EU/EEA. For investors, it signals that a product has cleared a common regulatory hurdle—like a passport for market access—reducing legal and market-entry risk and often widening sales opportunities across European markets.

class iia medical device regulatory

A Class IIa medical device is a mid‑risk healthcare product — higher risk than simple items like bandages but lower than life‑support machines — that must pass independent regulatory review and meet quality and safety checks before sale. For investors, this classification signals a moderate regulatory pathway, meaning development and approval take more time and cost than low‑risk devices but usually face fewer obstacles than high‑risk products, which affects funding needs, launch timing, and potential liability.

european medical device regulation (mdr) regulatory

A regulatory framework that sets safety, testing, labeling and post-market monitoring rules for medical devices sold in the European Union. Think of it like a strict building code and inspection system for medical products: compliance determines whether a device can be sold, how quickly it reaches patients, and what ongoing checks or recalls are required. For investors, MDR affects a device maker’s costs, approval timelines, market access and legal risk, which influence revenue and valuation.

class i designation regulatory

A class I designation is a regulatory label given to low-risk medical devices that are subject to the least stringent controls to ensure safety and effectiveness. For investors, it signals faster, less costly approval and lower regulatory hurdles—like a product passing a basic safety inspection rather than a full audit—reducing time and expense to bring the item to market and lowering the regulatory risk in a company’s product portfolio.

intraoral removables medical

Removable intraoral devices are medical or dental appliances that sit inside the mouth and can be taken out by the patient, such as dentures, removable partials, clear aligners, retainers, mouthguards and oral sleep-apnea trays. They matter to investors because they represent a recurring, service-driven market with predictable replacement cycles, regulatory and manufacturing requirements, and reimbursement dynamics—factors that influence revenue stability, growth potential and product liability risk.

biocompatibility medical

Biocompatibility is a measure of how well a medical material or device interacts with living tissue without causing harmful reactions, such as inflammation, toxicity, or rejection. For investors, it matters because strong biocompatibility speeds regulatory approval, lowers the risk of costly recalls or lawsuits, and increases patient and clinician acceptance — analogous to how a friendly guest makes a house more comfortable and welcome.

The CE Class IIa certification of TrueDent® resins expands patient access to digitally produced dentures and temporary restorations while supporting scalable adoption across European laboratories

MINNETONKA, Minn. & REHOVOT, Israel--(BUSINESS WIRE)-- Stratasys Ltd. (NASDAQ: SSYS) today announced that its TrueDent® resins have received CE marking as a Class IIa medical device, making them Europe’s first high-esthetic, monolithic 3D-printed denture solution to achieve certification in the more than $2 billion market. This milestone enables broader regulated clinical use and expands patient access to polychromatic, monolithic 3D-printed dentures, removable partial dentures, and crowns and bridges.

Stratasys TrueDent® Becomes the First High-esthetic, Monolithic 3D-printed Denture Solution to Achieve Certification in Europe

The expanded indication now includes intraoral removables for long-term use of more than 30 days as well as crowns and bridges, allowing dental laboratories to address a wider range of restorative cases through a single, integrated digital workflow. As European providers continue scaling digital denture production, the certification supports broader clinical adoption while strengthening the commercial foundation for growth across the region.

According to a 2024 iData report¹, the demand for denture solutions in Europe continues to grow as the region’s opportunity for dentures is projected to expand from USD 2.19 billion in 2023 to USD 2.45 billion by 2028.

Under the European Medical Device Regulation (MDR), Class IIa devices are subject to an independent third-party oversight and heightened regulatory scrutiny. For laboratories and clinicians, this classification reflects the regulatory standard commonly expected for restorative dental materials, strengthening confidence in routine clinical use and supporting broader market adoption across the region.

TrueDent-D™ was introduced in Europe in early 2025 under a CE Class I designation for denture production. While removable dentures are permitted under Class I, achieving CE Class IIa certification for TrueDent expands the indications and positions Stratasys to further penetrate the regulated European restorative market. It also gives dental labs, clinics, and patients even greater confidence in the validated biocompatibility, manufacturing controls, traceability and clinical safety and performance of the certified TrueDent resins.

“Achieving CE Class IIa certification for TrueDent is an important milestone and supports the continued expansion of our dental business in Europe,” said Chris Kabot, Vice President Dental, Stratasys. “By aligning TrueDent with the regulatory classification customers know and expect, we are providing additional clarity and confidence for clinicians and laboratories as they expand digital denture and temporary restoration workflows across the region.”

The transition to CE Class IIa requires no changes to print settings, formulation, workflow, or shelf life on the Stratasys J5 DentaJet® printer platform. A defined conversion kit enables existing customers to move seamlessly from TrueDent-D to TrueDent certified resins, preserving established production processes and outcomes.

TrueDent resin colors include: TrueDent® White , TrueDent® Clear, TrueDent® Cyan, TrueDent® Magenta, TrueDent® Yellow. For more information about the TrueDent digital denture application, visit the Stratasys TrueDent page.

¹ – iData Europe Market Report Suite for Dental Prosthetics, February 2024

About Stratasys

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, X/Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including Stratasys’ websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys, TrueDent,TrueDent-D, J5 and DentaJet are trademarks or registered trademarks of Stratasys Ltd. and/or its affiliates.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260317920719/en/

Media and Investor contacts:
Stratasys Corporate, North America & EMEA
Chris Reese
chris.reese@stratasys.com
+1 651 357 0877

Stratasys Corporate, Israel & EMEA
Erik Snider
Erik.Snider@stratasys.com
+972 74 745 6053

Investor Relations
Yonah Lloyd
Yonah.Lloyd@stratasys.com
+972 74 745 4919

Source: Stratasys Ltd.